Plus therapeutics announces upcoming participation at the 2022 snmmi therapeutics conference

Austin, texas, march 03, 2022 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (the “company”), a u.s. clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today announced it will sponsor and present an industry satellite symposium at the society of nuclear medicine and molecular imaging (snmmi) therapeutics conference, being held in-person march 10-12, 2022 at the hyatt regency, new orleans, louisiana.
pstv Ratings Summary
pstv Quant Ranking